Impaired IL-4 phosphorylation of STAT6 in EBV transformed B-cells

Journal of Surgical Research

Volumn 162, Issue 2, 2010, Pages 290-298

  Poritz, Lisa S ^a   Zhang, Wen Jie ^a   Thompson, Jennifer ^a   Boyer, Morgan ^a   Clark, Clarence ^a   Koltun, Walter A ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

B lymphocytes; Interferon gamma; Interleukin 4; STAT6

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; JANUS KINASE 1; JANUS KINASE 2; STAT6 PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL CULTURE; CELL STIMULATION; CELL TRANSFORMATION; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 77955981359     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.01.004     Document Type: Article

References (34)

1. Takeda K, Tanaka T, Shi W, et al. Essential role of Stat6 in IL-4 signaling. Nature 1996;380:627.
2. Nelms K, Keegan AS, Zamorano J, et al. The IL-4 receptor: Signaling mechanisms and biologic functions. Annu Rev Immunol 1999;17:701.
3. γ and IL-4 are involved. Gastroenterology 2006;130:1373.
4. γ. Int J Oncol 2004;24:447.
5. Zhang WJ, Koltun WA, Tilberg AF, et al. Genetic control of Inter-leukin-4-induced activation of the human signal transducer and activator of transcription 6 signaling pathway. Human Immunol 2003;64:402.
6. Hoey T, Schindler U. STAT structure and function in signaling. Curr Opin Genet Dev 1998;8:582.
7. Lei KD, Gaffen SL, Goldsmith MA. JAK/STAT signaling by cytokine receptors. Curr Opin Immunol 1998;10:271.
8. mada K, Leonared WJ. The Jak-STAT pathway. Mol Immunol 2000;37:1.
9. Hebenstreit D, Wirnsberger G, Horejs-Hoeck J, et al. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 2006;17:173.
10. Ohara J, Paul WE. Up-regulation of Interleukin 4/B-Cell stimulatory factor 1 receptor expression. PNAS 1988;85:8221.
11. Murata T, Puri RJ. Comparison of IL-13-and IL-4-induced signaling in EBV-immortalized human B cells. Cell Immunol 1997;175:33.
12. Andrews RP, Ericksen MB, Cunningham CM, et al. Analysis of the life cycle of Stat6 continuous cycling of Stat6 is required for IL-4 signaling. J Biol Chem 2002;277:36563.
13. Geiger TR, Martin JM. The Epstein-Barr Virus-Encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells. J Virol 2006;80:11838.
14. γ: An overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163.
15. Dickensheets HL, Vengataraman C, Schindler U, et al. Interferons inhibit activation of Stat6 by interleukin 4 inhuman monocytes by inducing SOCS-1 gene expression. Proc Natl Acad Sci 1999;96:10800.
16. Losman JA, Chen XP, Hilton D, et al. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction. J Immunol 1999;162:3770.
17. Starr R, Willson TA, Viney EM, et al. A family of cytokine-inducible inhibitors of signaling. Nature 1997;387:917.
18. Endo TA, Masuhara M, Yokouchi M, et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997;387:921.
19. Hanada T, Kinjyo I, Inagaki-Ohara K, et al. Negative regulation of cytokine signaling by CIS/SOCS family proteins and their roles in inflammatory diseases. Rev Physiol Biochem Pharmacol 2003;149:72.
20. γ inhibits STAT6 signal transduction and gene expression in human airway epithelial cells. Am J Respir Cell Mol Biol 2004;31:573.
21. γ suppresses STAT6 phosphorylation by inhibiting its recruitment to the IL-4 receptor. J Immunol 2005;174:1332.
22. Seki Y, Hayashi K, Matsumoto A, et al. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc Natl Acad Sci USA 2002;99:13003.
23. Haque SJ, Harbor P, Tabrizi M, et al. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4-and IL-13-dependent signal transduction. J Biol Chem 1998;273:33893.
24. Kopf M, Le Gros G, Bachmann M, et al. Disruptionofthe murine IL-4 blocks Th2 cytokine responses. Nature 1993;362:245.
25. Mosmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145.
26. γ and interleukin-4. J Surg Res 2008;144:1.
27. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987;236:944.
28. Niesser M, Vol BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995;101:428.
29. Hommes DW, Mikhajlova TL, Stoinov S, et al. Fontolizumab, a humanized anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease. Gut 2006;29:1131.
30. Bruewer M, Luegering A, Kucharzik T, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003;171:6164.
31. Poritz LS, Garver K, Green C, et al. Loss of the tight junction protein in dextran sulfate sodium induced colitis. J Surg Res 2007;140:12.
32. Gassler N, Rohr C, Schneider A, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001;281: G216.
33. Poritz LS, Garver K, Zhang W, et al. Dextran Sodium Sulfate (DSS) Induced Colitis in the Th2 Deficient Stat6 Knockout (Stat6-). Mouse. Dis Col Rectum 2004;46: A2.
34. Elrod JW, Laroux FS, Houghton J, et al. DSS-induced colitis is exacerbated in STAT-6 knockout mice. Inflamm Bowel Dis 2005;11:883.